Major Pharmaceutical Conferences and Courses: June 2020 to July 2020.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 155, doi. 10.1007/s40290-020-00331-2
- Publication type:
- Article
Works matching IS 11782595 AND DT 2020 AND VI 34 AND IP 2
Results: 8
1
2
Forum.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 141, doi. 10.1007/s40290-020-00330-3
- Publication type:
- Article
3
US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS).
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 135, doi. 10.1007/s40290-020-00329-w
- By:
- Publication type:
- Article
4
Critical Factors Shaping Strategy Development of an Innovative Medicine in Oncology.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 103, doi. 10.1007/s40290-020-00328-x
- By:
- Publication type:
- Article
5
Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 93, doi. 10.1007/s40290-020-00327-y
- By:
- Publication type:
- Article
6
Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 83, doi. 10.1007/s40290-020-00326-z
- By:
- Publication type:
- Article
7
Proposal for a New Stereochemically Informative Nonproprietary Drug Naming System.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 113, doi. 10.1007/s40290-020-00325-0
- By:
- Publication type:
- Article
8
Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 2, p. 127, doi. 10.1007/s40290-019-00323-x
- By:
- Publication type:
- Article